Literature DB >> 11310609

Iminosugars: potential inhibitors of liver glycogen phosphorylase.

P Jakobsen1, J M Lundbeck, M Kristiansen, J Breinholt, H Demuth, J Pawlas, M P Candela, B Andersen, N Westergaard, K Lundgren, N Asano.   

Abstract

The first synthesis of the single isomers (3R,4R,5R); (3S,4S,5S): (3R,4R,5S) and (3S,4S,5R) of 5-hydroxymethyl-piperidine-3,4-diol from Arecolin is reported, including the synthesis of a series of N-substituted derivatives of the (3R,4R,5R)-isomer (Isofagomine). The inhibitory effect of these isomers as well as of a series of N-substituted derivatives of the (3R,4R,5R)-isomer and selected hydroxypiperidine analogues on liver glycogen phosphorylase (GP) showed that the (3R,4R,5R) configuration was essential for obtaining an inhibitory effect at submicromolar concentration. The results also showed that all three hydroxy groups should be present and could not be substituted, nor were extra OH groups allowed if sub-micromolar inhibition should be obtained. Some inhibitory effect was retained for N-substituted derivatives of Isofagomine; however, N-substitution always resulted in a loss of activity compared to the parent compound, IC50 values ranging from 1 to 100 microM were obtained for simple alkyl, arylalkyl and benzoylmethyl substituents. Furthermore, we found that it was not enough to assure inhibitory effect to have the (R,R,R) configuration. Fagomine, the (2R,3R,4R)-2-hydroxymethylpiperidine-3,4-diol analogue, showed an IC50 value of 200 microM compared to 0.7 microM for Isofagomine. In addition, Isofagomine was able to prevent basal and glucagon stimulated glycogen degradation in cultured hepatocytes with IC50 values of 2-3 microM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310609     DOI: 10.1016/s0968-0896(00)00291-1

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase.

Authors:  Richard Steet; Stephen Chung; Wang-Sik Lee; Corey W Pine; Hung Do; Stuart Kornfeld
Journal:  Biochem Pharmacol       Date:  2006-12-15       Impact factor: 5.858

2.  Last step in the conversion of trehalose to glycogen: a mycobacterial enzyme that transfers maltose from maltose 1-phosphate to glycogen.

Authors:  Alan D Elbein; Irena Pastuszak; Alan J Tackett; Tyler Wilson; Yuan T Pan
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

3.  In vitro and in vivo comparative and competitive activity-based protein profiling of GH29 α-l-fucosidases.

Authors:  Jianbing Jiang; Wouter W Kallemeijn; Daniel W Wright; Adrianus M C H van den Nieuwendijk; Veronica Coco Rohde; Elisa Colomina Folch; Hans van den Elst; Bogdan I Florea; Saskia Scheij; Wilma E Donker-Koopman; Marri Verhoek; Nan Li; Martin Schürmann; Daniel Mink; Rolf G Boot; Jeroen D C Codée; Gijsbert A van der Marel; Gideon J Davies; Johannes M F G Aerts; Herman S Overkleeft
Journal:  Chem Sci       Date:  2015-02-09       Impact factor: 9.825

4.  Iminosugars: Effects of Stereochemistry, Ring Size, and N-Substituents on Glucosidase Activities.

Authors:  Luís O B Zamoner; Valquiria Aragão-Leoneti; Ivone Carvalho
Journal:  Pharmaceuticals (Basel)       Date:  2019-07-12

Review 5.  Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy.

Authors:  Christos E Zois; Adrian L Harris
Journal:  J Mol Med (Berl)       Date:  2016-02-17       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.